Atlas Trials

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

Clinical trial NCT00496548 · COMPLETED

Trial details

NCT number
NCT00496548
Sponsor
Vanderbilt University Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2007-08-01
Primary completion
2015-12-01
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.